Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Negative correlation between negative symptoms of schizophrenia and testosterone levels.

Goyal RO, Sagar R, Ammini AC, Khurana ML, Alias AG.

Ann N Y Acad Sci. 2004 Dec;1032:291-4.

PMID:
15677432
2.

Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.

Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A.

Arch Gen Psychiatry. 2003 Feb;60(2):133-41.

PMID:
12578430
3.

Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.

Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, Weizman A.

Eur Neuropsychopharmacol. 2004 Aug;14(4):267-73.

PMID:
15163435
4.

Alterations in DHEA metabolism in schizophrenia: two-month case-control study.

Ritsner M, Gibel A, Ram E, Maayan R, Weizman A.

Eur Neuropsychopharmacol. 2006 Feb;16(2):137-46. Epub 2005 Sep 1.

PMID:
16139994
5.

Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa.

Monteleone P, Luisi M, Colurcio B, Casarosa E, Monteleone P, Ioime R, Genazzani AR, Maj M.

Psychosom Med. 2001 Jan-Feb;63(1):62-8.

PMID:
11211066
6.

State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.

Ritsner M, Gibel A, Maayan R, Ratner Y, Ram E, Modai I, Weizman A.

Eur Neuropsychopharmacol. 2007 Mar;17(4):257-64. Epub 2006 Nov 14.

PMID:
17107774
7.

Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.

Iancu I, Tchernihovsky E, Maayan R, Poreh A, Dannon P, Kotler M, Weizman A, Strous RD.

Eur Neuropsychopharmacol. 2007 Jul;17(8):541-5. Epub 2007 Mar 8.

PMID:
17346944
8.

Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia.

Shirayama Y, Hashimoto K, Suzuki Y, Higuchi T.

Schizophr Res. 2002 Nov 1;58(1):69-74.

PMID:
12363392
9.

Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder.

Markianos M, Tripodianakis J, Sarantidis D, Hatzimanolis J.

J Affect Disord. 2007 Aug;101(1-3):255-8. Epub 2006 Dec 19.

PMID:
17182106
10.

Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia.

Ko YH, Jung SW, Joe SH, Lee CH, Jung HG, Jung IK, Kim SH, Lee MS.

Psychoneuroendocrinology. 2007 May;32(4):385-91. Epub 2007 Mar 28.

PMID:
17395394
11.
12.

Correlation between increased cortisol:DHEA ratio and malnutrition in HIV-positive men.

Christeff N, Melchior JC, Mammes O, Gherbi N, Dalle MT, Nunez EA.

Nutrition. 1999 Jul-Aug;15(7-8):534-9.

PMID:
10422082
13.

DHEAS and POMS measures identify cocaine dependence treatment outcome.

Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D, Setoda D.

Psychoneuroendocrinology. 2005 Jan;30(1):18-28.

PMID:
15358439
14.

Serum gonadal steroid hormones in young schizophrenic patients.

Oades RD, Schepker R.

Psychoneuroendocrinology. 1994;19(4):373-85.

PMID:
8047641
15.

[Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].

Ozsoy S, Eşel E, Hacimusalar Y, Candan Z, Kula M, Turan T.

Turk Psikiyatri Derg. 2008 Winter;19(4):341-8. Turkish.

17.

Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients.

Maayan R, Yagorowski Y, Grupper D, Weiss M, Shtaif B, Kaoud MA, Weizman A.

Biol Psychiatry. 2000 Oct 1;48(7):693-701.

PMID:
11032981
18.

Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease.

Markianos M, Panas M, Kalfakis N, Vassilopoulos D.

Neuro Endocrinol Lett. 2007 Apr;28(2):199-203.

PMID:
17435662
19.

Serum cortisol and dehydroepiandrosterone-sulfate levels in schizophrenic patients and their first-degree relatives.

Yıldırım O, Dogan O, Semiz M, Kilicli F.

Psychiatry Clin Neurosci. 2011 Oct;65(6):584-91. doi: 10.1111/j.1440-1819.2011.02252.x. Epub 2011 Sep 6.

20.

Lowered DHEA-S plasma levels in adult individuals with autistic disorder.

Strous RD, Golubchik P, Maayan R, Mozes T, Tuati-Werner D, Weizman A, Spivak B.

Eur Neuropsychopharmacol. 2005 May;15(3):305-9.

PMID:
15820420

Supplemental Content

Support Center